#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11868	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2260	522.7	0	.	n	.	0	A69G	SNP	69	69	A	335	335	G	660	G	625	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11868	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2260	522.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1716	1716	T	689	T,C	629,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11868	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2260	522.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1450	1450	C	673	C	630	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21346	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3692	577.0	0	.	n	.	0	T695C	SNP	695	695	T	1096	1096	C	650	C	606	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21346	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3692	577.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2372	2372	C	743	C	689	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21346	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3692	577.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2446	2446	A	703	A	667	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21346	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3692	577.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2998	2998	C	668	C,T	630,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1788	folP	855	855	100.0	folP.l15.c30.ctg.1	1683	106.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1078	1080	AGC	198;198;200	A;G,T;C	181;180,1;181	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4554	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3343	135.8	1	SNP	p	S91F	1	.	.	271	273	TTC	563	565	TTC	166;164;160	T;T;C	153;151;148	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4554	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3343	135.8	1	SNP	p	G95N	0	.	.	283	285	GGC	575	577	GGC	161;157;155	G;G,A;C	152;148,1;148	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4554	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3343	135.8	1	SNP	p	D95G	1	.	.	283	285	GGC	575	577	GGC	161;157;155	G;G,A;C	152;148,1;148	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1348	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1276	104.9	0	.	p	.	0	D79N	NONSYN	235	237	GAT	573	575	AAT	173;174;175	A;A;T	163;164;161	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1348	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1276	104.9	1	SNP	p	G45D	0	.	.	133	135	GGC	471	473	GGC	174;175;175	G;G;C	159;162;162	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	702	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	832	82.9	0	.	n	.	0	A197.	DEL	197	197	A	481	481	A	165	A	155	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4164	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2960	140.1	0	.	p	.	0	E91G	NONSYN	271	273	GAG	591	593	GGG	157;156;158	G;G;G	149;148;150	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4164	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2960	140.1	1	SNP	p	D86N	0	.	.	256	258	GAC	576	578	GAC	156;157;155	G;A;C	150;150;149	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4164	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2960	140.1	1	SNP	p	S87R	0	.	.	259	261	AGT	579	581	AGT	156;155;153	A;G;T	150;148;146	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4164	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2960	140.1	1	SNP	p	S87W	0	.	.	259	261	AGT	579	581	AGT	156;155;153	A;G;T	150;148;146	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4164	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2960	140.1	1	SNP	p	S87I	0	.	.	259	261	AGT	579	581	AGT	156;155;153	A;G;T	150;148;146	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4164	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2960	140.1	1	SNP	p	S88P	0	.	.	262	264	TCC	582	584	TCC	152;151;152	T;C;C	146;143;145	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3680	parE	1986	1986	99.95	parE.l6.c30.ctg.1	2634	139.3	0	.	p	.	0	R427H	NONSYN	1279	1281	CGC	1569	1571	CAC	175;175;177	C;A,C;C	162;161,1;163	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3680	parE	1986	1986	99.95	parE.l6.c30.ctg.1	2634	139.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	160;160;160	G,T;G;C	151,1;153;150	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1293	1295	GCA	176;173;173	G;C;A	165;163;164	penA.44.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1296	1298	ATC	174;174;177	A;T;C	166;168;167	penA.44.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1308	1310	GTG	181;179;178	G;T;G,A	168;163;165,1	penA.44.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1308	1310	GTG	181;179;178	G;T;G,A	168;163;165,1	penA.44.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1812	1814	ACC	192;190;191	A;C;C	172;177;177	penA.44.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	T502V	0	.	.	1504	1506	ACG	1866	1868	ACG	173;176;176	A;C;G	134;144;142	penA.44.001:1:1:T502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	T502P	0	.	.	1504	1506	ACG	1866	1868	ACG	173;176;176	A;C;G	134;144;142	penA.44.001:1:1:T502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1989	1991	GGC	154;152;149	G;G;C	143;142;138	penA.44.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1998	2000	GGC	148;148;148	G;G;C	138;134;135	penA.44.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3398	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2448	138.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2016	2018	CTG	124;123;124	C,G;T,G;G	93,2;92,1;100	penA.44.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4712	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3137	149.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1618	1620	CCG	170;171;172	C,G;C;G	153,1;159;156	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1814	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1883	95.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	557	557	C	116	C	105	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2222	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1556	141.9	1	SNP	p	G120K	1	.	.	358	360	AAG	621	623	AAG	169;172;174	A;A;G	156;162;164	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2222	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1556	141.9	1	SNP	p	N121D	0	.	.	361	363	AAC	624	626	AAC	169;168;168	A;A;C	159;155;157	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2222	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1556	141.9	1	SNP	p	A121N	1	.	.	361	363	AAC	624	626	AAC	169;168;168	A;A;C	159;155;157	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	8644	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4876	176.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2014	2016	CAT	180;180;180	C;A;T	172;172;171	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	922	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	967	94.7	1	SNP	p	V57M	1	.	.	169	171	ATG	528	530	ATG	187;188;186	A;T;G	174;174;172	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
